Success of prostaglandin E 2 in structure–function is a challenge for structure-based therapeutics
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Prostaglandin (PG) E2 is almost ubiquitous in humans and evokes potent diverse actions. Utility is the price of its perfection. PGE2 is a founding member of the PGs, a class of mediators that belongs to the still growing family of bioactive autacoids known as the eicosanoids (1–3). The main classes include enzymatically generated products such as thromboxanes, leukotrienes, lipoxins, and EETs, as well as others that are produced via nonenzymatic mechanisms, e.g., isoprostanes and cyclopentaeone PGs that are increasing in number and appreciation (4, 5). PGE2 regulates key responses in the major human systems including reproductive, gastrointestinal, neuroendocrine, and immune (Fig. 1). Formed by conversion of arachidonic acid via cyclooxygenase (COX) and specific synthases, PGE2 stereospecifically exerts potent (nano- to micromolar range) tissue- and cell type-selective actions (1–6). The importance of PGs in inflammation was brought into view by the discovery of J. Vane and colleagues (7) that nonsteroidal antiinflammatory drugs (NSAIDs) like aspirin, that at the time were used clinically without a known mechanism, act by inhibiting COX production of PGs and thromboxanes. Although highly effective, the COX inhibitors (both COX-1 and COX-2) of today's clinics are still rather blunt therapies at the molecular level, because they not only block the formation of individual PGs but also knock out other “bystander” eicosanoids that may be needed to maintain homeostasis. This can lead to unwanted side effects in multiple systems, i.e., ulcers and constipation. Hence there remains considerable room for improvement in this clinical area. In this issue of PNAS, Trebino et al. (8) studied the pathogenesis of collagen-induced arthritis by using microsomal PGE synthase-1 (mPGES1) deficient mice and demonstrate the contributions of this enzyme and PGE2 in chronic inflammation and pain. Their results provide in vivo validation of this …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationMurakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Oh-ishi, S., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003505200 · Cited by 964
Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., & Kudo, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003504200 · Cited by 708
Cited by
Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases
Park, J. Y., Pillinger, M. H., & Abramson, S. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.016 · Cited by 793
Loynes, C. A., Lee, J. A., Robertson, A. L., Steel, M. J., Ellett, F., Feng, Y., Levy, B. D., Whyte, M. K. B., & Renshaw, S. A. (2018) · Science Advances · doi:10.1126/sciadv.aar8320 · Cited by 222
Self-citationCellular senescence involves an intracrine prostaglandin E2 pathway in human fibroblasts
Martien, S., Pluquet, O., Vercamer, C., Malaquin, N., Martin, N., Gosselin, K., Pourtier, A., & Abbadie, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.04.005 · Cited by 50
Yang, H. H., Kim, C., Jung, B., Kim, K. S., & Kim, J.-R. (2011) · Biogerontology · doi:10.1007/s10522-010-9318-z · Cited by 22
Metadata
- Authors
- Serhan, C. N., & Levy, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-07-14
- Volume
- 100
- Issue
- 15
- Pages
- 8609-8611
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2037341294
- Cited by
- 98
- References
- 4
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.